Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to those with a biological valve, new research led by the University of Bristol ...

“We found that among people with no active disease or clinically abnormal biomarkers at baseline, every 4.1 years of additional (biological) heart age (one standard deviation) conferred an ...

Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to those with a biological valve, new research has found.

A new biological patch, designed from heart cells grown in the laboratory, could bring a glimmer of hope in the treatment of advanced heart failure. Implanted in about fifteen patients, this device ...

This pioneering innovation envisions the development of biological heart valves that can grow and be accommodated naturally within the human body. This opens the door to a new era in heart disease ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Overview: Shanghai Bio-heart Biological Technology Co., Ltd. (SEHK:2185) is a company focused on developing and commercializing innovative cardiovascular medical devices, with a market cap of ...